Last Updated: July 2026
Antiepileptic drugs are a well-documented cause of vitamin D depletion. Enzyme-inducing AEDs like phenytoin, carbamazepine, and phenobarbital activate liver cytochrome P450 enzymes that metabolize vitamin D more rapidly than usual. This accelerated catabolism reduces the amount of vitamin D available for conversion to its active form, lowering serum levels. Over months and years of AED use, this depletion can reduce calcium absorption and affect bone density in ways that are not immediately obvious but accumulate meaningfully over time.
Natural Rhythm Nutrition is a GMP-certified, FDA-registered supplement brand founded in 2019. Natural Rhythm has supported over 100,000 customers with clean, targeted nutritional formulas. Every product is manufactured in an SQF-certified facility with rigorous quality controls.
Key Takeaways
- Enzyme induction: Enzyme-inducing AEDs activate CYP450 liver enzymes that break down vitamin D faster than normal, reducing circulating 25(OH)D levels over time.
- Bone health connection: Low vitamin D from AED use reduces calcium absorption, which over years can affect bone mineral density in adults and bone development in children on long-term therapy.
- Not all AEDs carry equal risk: Enzyme-inducing AEDs (phenytoin, carbamazepine, oxcarbazepine, phenobarbital) carry the highest risk. Newer AEDs like levetiracetam have lower enzyme-inducing activity.
- Vitamin D3K2: Vitamin D3K2 from Natural Rhythm combines D3 with vitamin K2 to support calcium utilization alongside vitamin D replenishment.
- Test and monitor: Ask your neurologist about checking 25(OH)D levels regularly. A target range of 40 to 60 ng/mL is commonly referenced for people on enzyme-inducing AEDs.
Which antiepileptic drugs deplete vitamin D?
Enzyme-inducing antiepileptic drugs are the category most strongly linked to vitamin D depletion. Phenytoin, carbamazepine, phenobarbital, and primidone are classic enzyme inducers that have been associated with lower vitamin D levels since the 1970s. Oxcarbazepine has intermediate enzyme-inducing activity and carries a moderate depletion risk. Valproate, an older AED, may affect vitamin D through a different pathway related to its effect on liver function rather than direct enzyme induction.
Newer AEDs introduced in the past two decades generally carry lower depletion risk. Levetiracetam, lamotrigine, and lacosamide have minimal enzyme-inducing activity and are not strongly linked to vitamin D depletion in clinical studies. According to the NIH Office of Dietary Supplements, certain medications including anticonvulsants can reduce the body's ability to maintain adequate vitamin D status. If you are transitioning between AEDs, ask your neurologist how the change may affect your nutrient monitoring plan.
How do AEDs accelerate vitamin D catabolism?
AEDs accelerate vitamin D catabolism by inducing hepatic CYP450 enzymes, specifically CYP3A4 and CYP2C9, which are responsible for converting active vitamin D metabolites into inactive forms. Normally, 25-hydroxyvitamin D (25(OH)D) circulates in the blood as a reserve form with a half-life of several weeks. When enzyme-inducing AEDs are present, these enzymes convert 25(OH)D to its inactive catabolites more rapidly, effectively shortening the vitamin D half-life and lowering circulating reserves.
The downstream effect is a reduction in the conversion of 25(OH)D to 1,25-dihydroxyvitamin D, the fully active form that regulates calcium absorption in the gut. Research in PubMed confirmed that low vitamin D status is associated with impaired calcium metabolism and downstream effects on musculoskeletal health (PMID 22566513). For people on long-term enzyme-inducing AEDs, this process operates continuously, making periodic monitoring essential for catching depletion before it becomes clinically significant.

What are the signs of vitamin D depletion from AED use?
The signs of vitamin D depletion from AED use develop gradually and are often mild for years before becoming clinically obvious. Early signs include muscle weakness, bone discomfort, and fatigue that does not resolve with adequate sleep. These effects reflect impaired calcium metabolism rather than vitamin D's other roles. In children on long-term AED therapy, low vitamin D can affect the rate of bone mineralization during growth, which is a serious consideration during developmental years.
In adults, prolonged vitamin D deficiency from AED use is associated with lower bone mineral density and an increased risk of fractures. Many people on long-term AEDs have 25(OH)D levels below 20 ng/mL, which is the threshold for clinical deficiency, without knowing it because routine blood panels often do not include vitamin D unless specifically requested. Standard neurological follow-up does not always include nutrient testing. Advocating for a 25(OH)D test at least once per year is a practical self-management step for anyone on enzyme-inducing AEDs.
How should vitamin D be supplemented alongside AEDs?
Vitamin D3 (cholecalciferol) is the preferred supplemental form because it raises and maintains 25(OH)D levels more effectively than D2 (ergocalciferol). For people on enzyme-inducing AEDs, standard supplemental doses of 1,000 to 2,000 IU per day may not be sufficient to maintain target levels because the medication continues to accelerate catabolism. Many neurologists and endocrinologists recommend starting at 2,000 IU per day and adjusting based on lab results, sometimes requiring 4,000 IU or more under medical supervision to maintain a 25(OH)D level of 40 to 60 ng/mL.
Vitamin K2 is an important co-supplement because it directs calcium to bones rather than soft tissues. As vitamin D supplementation increases calcium absorption, adequate K2 helps ensure that calcium goes where the body needs it. Natural Rhythm's Vitamin D3K2 pairs D3 with MK-7 form vitamin K2, which has the longest half-life in the body among K2 forms. This pairing supports vitamin D's role in calcium metabolism while K2 directs that calcium to bone and away from arterial tissue.
Vitamin D3K2 from Natural Rhythm supports calcium utilization alongside targeted D3 replenishment. Free shipping is available on orders over $35.
How often should people on AEDs test their vitamin D levels?
People on enzyme-inducing AEDs should test their 25(OH)D level at least once per year, with twice-yearly testing recommended for those who have had low levels or who are on multiple enzyme-inducing AEDs. Testing in late winter or early spring, when sun exposure and therefore natural vitamin D production has been lowest, captures the most relevant baseline for deciding whether supplementation needs adjustment.
A target 25(OH)D level of 40 to 60 ng/mL gives adequate reserve for calcium metabolism without approaching toxicity thresholds. Levels below 20 ng/mL are classified as deficient; levels between 20 and 30 ng/mL are considered insufficient. Levels above 100 ng/mL from prolonged high-dose supplementation can cause vitamin D toxicity, so testing while adjusting doses is important. Your neurologist can coordinate this testing or refer you to an endocrinologist if more frequent monitoring is needed.
|
AED Type |
Enzyme Induction Level |
Vitamin D Depletion Risk |
Monitoring Recommendation |
|---|---|---|---|
|
Phenytoin, Carbamazepine, Phenobarbital |
High |
High |
Test 25(OH)D twice yearly; supplement at higher D3 doses |
|
Oxcarbazepine |
Moderate |
Moderate |
Test annually; supplement at standard to moderate doses |
|
Valproate |
Low-moderate (different pathway) |
Moderate |
Test annually; monitor liver function alongside D |
|
Levetiracetam, Lamotrigine, Lacosamide |
Minimal |
Low |
Standard annual monitoring unless other risk factors present |
|
N/A |
Supports replenishment |
Pair with testing; adjust dose based on 25(OH)D results |
Frequently Asked Questions
Do all antiepileptic drugs deplete vitamin D?
No. Enzyme-inducing AEDs like phenytoin, carbamazepine, and phenobarbital carry the highest risk because they activate liver enzymes that break down vitamin D faster than normal. Newer AEDs like levetiracetam have minimal enzyme-inducing activity and are not strongly linked to vitamin D depletion. If you are unsure whether your specific AED is enzyme-inducing, ask your neurologist or pharmacist.
How low does vitamin D get on long-term AED therapy?
Studies of people on long-term enzyme-inducing AEDs report 25(OH)D levels commonly below 20 ng/mL, the clinical deficiency threshold, in a significant portion of patients who are not supplementing. The exact level depends on sun exposure, baseline diet, duration of AED use, and whether enzyme-inducing drugs are used alone or in combination with others.
Is vitamin D3 better than D2 for people on AEDs?
Yes. Vitamin D3 (cholecalciferol) raises 25(OH)D levels more effectively than D2 (ergocalciferol) and sustains those levels for longer. For people whose AEDs are continuously breaking down vitamin D, the more efficient and longer-lasting D3 form provides a practical advantage. Most clinical guidelines recommend D3 for supplementation in adults.
Do I need a prescription dose of vitamin D if I am on AEDs?
Some people on enzyme-inducing AEDs need doses higher than the standard 1,000 to 2,000 IU range to maintain adequate 25(OH)D levels. Whether this requires a prescription-strength dose depends on your lab results. Doses above 4,000 IU per day are generally recommended under medical supervision with regular lab monitoring. Start with a standard dose and have your 25(OH)D retested after 8 to 12 weeks to determine whether adjustment is needed.
Can vitamin D supplementation affect my AED levels?
Vitamin D supplementation does not appear to significantly affect the blood levels of common AED medications. There is no well-documented pharmacokinetic interaction between standard vitamin D supplements and most AEDs. However, because individual metabolism varies, informing your neurologist of any new supplement is always a sensible step in managing your overall treatment plan.
Why does vitamin D matter for bone health during long-term AED use?
Vitamin D is essential for calcium absorption from the gut. When vitamin D is low, calcium absorption drops, and the body compensates by pulling calcium from bone tissue to maintain blood calcium levels. Over years of AED-related vitamin D depletion, this slow calcium transfer out of bone can reduce bone mineral density, making fractures more likely from falls or minor trauma.
What is the target 25(OH)D level for people on AEDs?
A 25(OH)D level of 40 to 60 ng/mL is commonly referenced as the target range for people on enzyme-inducing AEDs who are actively supplementing. This range provides enough circulating reserve to support calcium absorption even when the AED is accelerating vitamin D catabolism. Levels below 30 ng/mL are considered insufficient for people under this added metabolic pressure.
Can I use sunlight to keep my vitamin D up while on AEDs?
Sunlight can support vitamin D production through the skin, but it is often insufficient to fully offset the depletion caused by enzyme-inducing AEDs. Season, latitude, skin tone, and the amount of skin exposed all affect how much vitamin D sunlight provides. In the fall and winter months, or for people who spend most time indoors, sunlight alone cannot maintain adequate 25(OH)D levels even without the added depletion pressure from AED therapy. Supplementation remains necessary for reliable status.
Should my child on AEDs take vitamin D?
Children on enzyme-inducing AEDs need vitamin D monitoring because low vitamin D can affect bone development during growth years. The dose and target level differ for children and should be guided by a pediatric neurologist or endocrinologist. Proactive testing and supplementation are especially important for children on long-term AED therapy.
Executive Summary
Enzyme-inducing antiepileptic drugs including phenytoin, carbamazepine, and phenobarbital activate the CYP450 enzyme system in the liver, which accelerates the breakdown of vitamin D into inactive metabolites. This reduces circulating 25-hydroxyvitamin D levels, impairing calcium absorption and weakening bone over time. Studies show that people on long-term enzyme-inducing AEDs have significantly lower bone mineral density than age-matched controls. Supplementation of 1,000 to 2,000 IU of vitamin D3 daily is frequently used in this population, with some patients requiring higher amounts under medical supervision. Calcium co-supplementation and bone density monitoring are the standard management strategies for this known drug-nutrient interaction.
What Should You Do Next?
Ask your neurologist at your next appointment about having your 25(OH)D level checked. If you are on an enzyme-inducing AED and have not been tested recently, make this a priority. Once you have your baseline, work with your provider to determine the right supplemental D3 dose to reach and maintain the 40 to 60 ng/mL range.
Vitamin D3K2 from Natural Rhythm pairs D3 with K2 (MK-7) to support calcium metabolism and direct calcium where the body needs it most. Natural Rhythm products are Gluten-Free, Dairy-Free, Soy-Free, Non-GMO, and Vegetarian friendly, made in GMP-certified, FDA-registered, SQF-certified facilities. Free shipping is available on orders over $35, with a 100% satisfaction guarantee.
People Also Read
About the Author
Ethan Lewis is the Owner of Natural Rhythm Nutrition. Natural Rhythm was founded to help people find calm, restful sleep and genuine wellness through science-backed, clean supplements. Every product is Gluten-Free, Dairy-Free, Soy-Free, Non-GMO, and Vegetarian friendly, made in GMP Certified, FDA-registered, SQF-certified facilities.
Expertise: Sleep Support, Stress Management, Heart Health, Gut Health, Clean Supplement Formulation
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.